Skye Bioscience, Inc. SEC filings SKYE
Skye Bioscience, Inc. has 631 filings in SEC EDGAR's recent list, going back to Mar 25, 2011. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 11, 2026 (agreement ended, officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| PREM14A | Filing | Oct 26, 2026 | Oct 26, 2026 |
| DEFA14A | Additional proxy material | Sep 11, 2026 | — |
| DEFA14A | Additional proxy material | Aug 24, 2026 | — |
| DEFA14A | Additional proxy material | Aug 20, 2026 | — |
| DEFA14A | Additional proxy material | Aug 19, 2026 | — |
| DEFA14A | Additional proxy material | Aug 14, 2026 | — |
| DEFA14A | Additional proxy material | Apr 16, 2026 | — |
| DEF 14A | Proxy statement | Apr 16, 2026 | May 26, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 6, 2026 | Apr 6, 2026 |
| PREM14A | Def 14a | Apr 6, 2026 | Apr 6, 2026 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Apr 25, 2025 |
| DEF 14A | Proxy statement | Sep 23, 2024 | Sep 23, 2024 |
| PRE 14A | Preliminary proxy statement | Sep 13, 2024 | Sep 13, 2024 |
| DEF 14C | Information statement | Oct 17, 2023 | Oct 16, 2023 |
| PRE 14C | Filing | Oct 3, 2023 | Sep 29, 2023 |
| DEFA14A | Additional proxy material | Sep 1, 2022 | — |
| DEFM14A | Filing | Aug 31, 2022 | — |
| PREM14A | Filing | Aug 15, 2022 | Aug 12, 2022 |
| DEF 14A | Proxy statement | Dec 22, 2020 | Dec 22, 2020 |
| PRE 14A | Preliminary proxy statement | Dec 11, 2020 | Dec 10, 2020 |
| DEF 14C | Information statement | Oct 30, 2019 | Oct 28, 2019 |
| DEF 14C | Information statement | Mar 4, 2019 | Feb 28, 2019 |
| PRE 14C | Filing | Feb 20, 2019 | Feb 19, 2019 |
| DEF 14C | Information statement | Oct 25, 2018 | Oct 25, 2018 |
| PRE 14C | Filing | Oct 15, 2018 | Oct 5, 2018 |
| DEF 14A | Proxy statement | May 27, 2016 | Jul 12, 2016 |
| DEF 14A | Proxy statement | Jun 10, 2015 | Jun 10, 2015 |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SKYE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1516551
- Former names
- Emerald Bioscience, Inc. (until Jan 7, 2021); Nemus Bioscience, Inc. (until Mar 14, 2019); LOAD GUARD LOGISTICS, INC. (until Oct 30, 2014); LOAD GUARD TRANSPORTATION, INC. (until Nov 7, 2012)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.